Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot biomarker study for severe neutrophilic inflammatory asthma
NL-OMON42933Active, not recruiting
- Sponsor
- Rijnstate
- Start
- Jul 2017
- Countries
- 1
01
Overview
Open-label trial in severe asthma, sponsored by Rijnstate. Primary endpoint: Biomarker comparison across asthma phenotypes. Started Jul 2017; status: active, not recruiting.
02
Conditions
severe asthma
Beyond the preview
Go deeper on NL-OMON42933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42933.